内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

Diabetes Care：2型糖尿病QT间期可独立预测死亡风险

2014-03-07 永燊 编译 中国医学论坛报糖尿病手机报

2型糖尿病QT间期死亡风险
关注

美国糖尿病心脏研究(Diabetes Heart Study)显示，在2型糖尿病人群中，心率校正QT(QTc)间期是全因死亡及心血管病(CVD)死亡的独立预测因素。论文2月26日在线发表于《糖尿病护理》(Diabetes Care)杂志。研究者纳入1020例2型糖尿病患者，基线时这些患者没有心房颤动、严重心室传导障碍及没有接受抗心律失常治疗。中位随访8.5年后，204例患者死亡。在校正多变量模型中

美国糖尿病心脏研究(Diabetes Heart Study)显示，在2型糖尿病人群中，心率校正QT(QTc)间期是全因死亡及心血管病(CVD)死亡的独立预测因素。论文2月26日在线发表于《糖尿病护理》(Diabetes Care)杂志。

研究者纳入1020例2型糖尿病患者，基线时这些患者没有心房颤动、严重心室传导障碍及没有接受抗心律失常治疗。中位随访8.5年后，204例患者死亡。在校正多变量模型中，QTc间期每增加一个标准差(SD)与全因死亡风险升高18%及CVD死亡风险升高29%相关。

原始出处：
Amanda J. Cox1,2,3, Amir Azeem4, Joseph Yeboah4, Elsayed Z. Soliman5, Shivani R. Aggarwal4, Alain G. Bertoni5, J. Jeffrey Carr6, Barry I. Freedman7, David M. Herrington4 and Donald W. Bowden1,2,3⇑.Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart Study.Diabetes Care February 26, 2014 doi: 10.2337/dc13-1257

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636831, encodeId=47ef1636831ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 22 10:11:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759418, encodeId=89731e59418be, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 20 07:11:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901192, encodeId=f50f190119296, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Oct 05 09:11:00 CST 2014, time=2014-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255470, encodeId=79db12554e0d0, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399443, encodeId=6082139944337, content=<a href='/topic/show?id=72d615003a5' target=_blank style='color:#2F92EE;'>#QT间期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15003, encryptionId=72d615003a5, topicName=QT间期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8202208740, createdName=xinmeili, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=)]
    2014-08-22 ms9608593228839890

    #DIA#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1636831, encodeId=47ef1636831ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 22 10:11:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759418, encodeId=89731e59418be, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 20 07:11:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901192, encodeId=f50f190119296, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Oct 05 09:11:00 CST 2014, time=2014-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255470, encodeId=79db12554e0d0, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399443, encodeId=6082139944337, content=<a href='/topic/show?id=72d615003a5' target=_blank style='color:#2F92EE;'>#QT间期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15003, encryptionId=72d615003a5, topicName=QT间期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8202208740, createdName=xinmeili, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=)]
    2014-06-20 智智灵药

    #BET#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1636831, encodeId=47ef1636831ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 22 10:11:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759418, encodeId=89731e59418be, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 20 07:11:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901192, encodeId=f50f190119296, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Oct 05 09:11:00 CST 2014, time=2014-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255470, encodeId=79db12554e0d0, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399443, encodeId=6082139944337, content=<a href='/topic/show?id=72d615003a5' target=_blank style='color:#2F92EE;'>#QT间期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15003, encryptionId=72d615003a5, topicName=QT间期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8202208740, createdName=xinmeili, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=)]
    2014-10-05 木头人513

    #Diabetes#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1636831, encodeId=47ef1636831ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 22 10:11:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759418, encodeId=89731e59418be, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 20 07:11:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901192, encodeId=f50f190119296, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Oct 05 09:11:00 CST 2014, time=2014-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255470, encodeId=79db12554e0d0, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399443, encodeId=6082139944337, content=<a href='/topic/show?id=72d615003a5' target=_blank style='color:#2F92EE;'>#QT间期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15003, encryptionId=72d615003a5, topicName=QT间期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8202208740, createdName=xinmeili, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=)]
    2014-03-09 quxin068

    #死亡风险#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1636831, encodeId=47ef1636831ae, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 22 10:11:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759418, encodeId=89731e59418be, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Jun 20 07:11:00 CST 2014, time=2014-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901192, encodeId=f50f190119296, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Sun Oct 05 09:11:00 CST 2014, time=2014-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255470, encodeId=79db12554e0d0, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399443, encodeId=6082139944337, content=<a href='/topic/show?id=72d615003a5' target=_blank style='color:#2F92EE;'>#QT间期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15003, encryptionId=72d615003a5, topicName=QT间期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8202208740, createdName=xinmeili, createdTime=Sun Mar 09 04:11:00 CST 2014, time=2014-03-09, status=1, ipAttribution=)]
    2014-03-09 xinmeili

    #QT间期#

    0

相关资讯

Clin Endocrinol：循环TRAIL或可反映2型糖尿病内皮细胞功能

肿瘤坏死因子（TNF）相关的凋亡诱导配体（TRAIL）是TNF细胞因子家族的一员，在调节细胞死亡和炎症反应中发挥重要作用。有研究表明TRAIL与动脉粥样硬化有关，而内皮细胞功能紊乱是动脉粥样硬化早期的生理变化。然而，迄今为止，尚无糖尿病患者循环TRAIL与内皮细胞功能紊乱之间关系的资料。为此，来自广州军区武汉总医院的向光大教授及其团队进行了一向研究，探讨新诊断2型糖尿病患者糖尿病治疗前后循环TRA

Diabetologia：胰岛炎或与2型糖尿病胰岛功能紊乱有关

2型糖尿病发病机制中包含胰岛素抵抗和胰岛功能紊乱。2型糖尿病病程中的慢性炎症反应不仅可影响胰岛，而且也可影响胰岛素靶器官。然而，2型糖尿病胰岛炎症反应的性质，以及其对2型糖尿病患者胰岛功能的影响尚不清楚。此外，正常人和2型糖尿病患者胰岛中免疫细胞表达情况尚不确定。 为此，来自美国东弗吉尼亚医学院的Galkina教授及其团队进行了一项研究，探讨2型糖尿病患者胰岛中促炎细

Diabetes Care：严重低血糖或与2型糖尿病患者癌症发生率较高相关

中国香港学者探讨了2型糖尿病患者发生严重低血糖的临床情况与其临床转归(包括死亡和所有部位癌症发生)的相关性，结果表明，严重低血糖与高龄、肾功能不全、血糖控制不佳和癌症亚表现[低体质指数(BMI)、低水平的低密度脂蛋白胆固醇(LDL-C)和低甘油三酯(TG)]存在相关性。论文2月10日在线发表于《糖尿病护理》(Diabetes Care)杂志。【原文下载】 研究纳入8767例在入组前的12

Diabetes Care：高Omega-3摄入可降低2型糖尿病风险

根据一项前瞻性基于人口的研究结果，摄取鱼类时的客观生物标志物、血清长链Omega-3多不饱和脂肪酸(PUFA)值较高，与2型糖尿病长期风险较低有关。【原文下载】 东芬兰大学营养流行病学客座教授Virtanen博士等人在发表于《糖尿病护理》杂志的报告中解释，饮食因素中，来自鱼类和其他海鲜的长链omega-3 PUFA、二十碳五烯酸(EPA)和十二碳六烯酸(DHA)，因为对心血管疾病风险，以及对糖尿

Diabetes Care：短期强化胰岛素治疗可降低2型糖尿病患者血糖变异性

加拿大一项研究表明，在早期2型糖尿病患者中，通过短期强化胰岛素治疗(IIT)改善β细胞功能，可降低血糖变异性。论文2月18日在线发表于《糖尿病护理》(Diabetes Care)。此项研究共纳入61例平均病程为3.0年的2型糖尿病患者。受试者均接受为期4周的IIT;IIT由基础地特胰岛素和餐前门冬胰岛素组成。通过每日6次的自测血糖变异系数评估第一和第四周的血糖变异性。利用胰岛素分泌敏感指数-2(I

Diabetologia：坚持地中海饮食或可降低2型糖尿病发生

研究要点： 该研究探讨不同饮食习惯与糖尿病发生的关系； 该研究发现MDS与糖尿病风险呈负相关；GL与糖尿病风险呈正相关。 饮食在糖尿病预防中的作用尚不确定。为了探讨两种不同的饮食习惯与糖尿病发生的关系，来自意大利米兰大学C. La Vecchia教授及其团队进行了一项研究，该研究发现低GL饮食可以降低2型糖尿病的发生。该研究结果发表在2013年11月的Diabetolog